M
Mingting Chen
Researcher at Chinese Center for Disease Control and Prevention
Publications - 9
Citations - 525
Mingting Chen is an academic researcher from Chinese Center for Disease Control and Prevention. The author has contributed to research in topics: Tuberculosis & Population. The author has an hindex of 5, co-authored 8 publications receiving 424 citations.
Papers
More filters
Journal ArticleDOI
Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data
Lixia Wang,Hui Zhang,Yunzhou Ruan,Daniel P. Chin,Yinyin Xia,Shiming Cheng,Mingting Chen,Yanlin Zhao,Shiwen Jiang,Xin Du,Guangxue He,Jun Li,Shengfen Wang,Wei Chen,Caihong Xu,Fei Huang,Xiaoqiu Liu,Yu Wang +17 more
TL;DR: Marked improvement in tuberculosis treatment, driven by a major shift in treatment from hospitals to the public health centres (that implemented the DOTS strategy) was largely responsible for this epidemiological effect.
Journal ArticleDOI
Effect of a comprehensive programme to provide universal access to care for sputum-smear-positive multidrug-resistant tuberculosis in China: a before-and-after study
Renzhong Li,Yunzhou Ruan,Qiang Sun,Xiexiu Wang,Mingting Chen,Hui Zhang,Yanlin Zhao,Jin Zhao,C Chen,Caihong Xu,Wei Su,Yu Pang,Jun Cheng,Junying Chi,Qian Wang,Yunting Fu,Shitong Huan,Lixia Wang,Yu Wang,Daniel P. Chin +19 more
TL;DR: This comprehensive programme substantially increased access to diagnosis, quality treatment, and affordable treatment for MDRTB in four Chinese cities, and greater financial risk protection for patients is needed.
Journal ArticleDOI
Clinical outcome of multidrug-resistant tuberculosis patients receiving standardized second-line treatment regimen in China
TL;DR: Less than half of MDR-TB patients receiving standardized second-line treatment regimen meet the definition of successful treatment during a 3-year period in China, demonstrating that more attention should be paid to this population at high-risk of poor clinical outcome.
Journal ArticleDOI
The Global Fund in China: Multidrug-resistant tuberculosis nationwide programmatic scale-up and challenges to transition to full country ownership
Lixia Wang,Renzhong Li,Caihong Xu,Hui Zhang,Yunzhou Ruan,Mingting Chen,Dongmei Wang,Emilio Dirlikov,Xin Du,Jin Zhao,Yanlin Zhao,Sheng Fen Wang,Yuhong Liu,Liang Li,Dennis Falzon,Yanni Sun,Yu Wang,Bernhard Schwartländer,Fabio Scano +18 more
TL;DR: China now has a chance to cement its status in TB control by strengthening future financing and ensuring ongoing commitment to quality service delivery, and jeopardise investments made for MDR-TB control and care.
Journal ArticleDOI
Is knowledge retained by healthcare providers after training? A pragmatic evaluation of drug-resistant tuberculosis management in China.
TL;DR: This study, the first to assess knowledge retention of MDR-TB HCPs 1 year after training, showed an overall positive long-term impact of lecture-style group training on participants’ knowledge.